136 related articles for article (PubMed ID: 12007506)
21. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
Cornelius EA
J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
[TBL] [Abstract][Full Text] [Related]
22. Expression of hybrid Ia molecules on the cell surface of reticulum cell sarcomas that are undetectable on host SJL/J lymphocytes.
Wilbur SM; Bonavida B
J Exp Med; 1981 Mar; 153(3):501-13. PubMed ID: 6166700
[TBL] [Abstract][Full Text] [Related]
23. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
[TBL] [Abstract][Full Text] [Related]
24. Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas.
Ponzio NM; Thorbecke GJ
Semin Cancer Biol; 2000 Oct; 10(5):331-40. PubMed ID: 11100880
[TBL] [Abstract][Full Text] [Related]
25. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.
Katz IR; Lerman SP; Ponzio NM; Shreffler DC; Thorbecke GJ
J Exp Med; 1980 Feb; 151(2):347-61. PubMed ID: 6985949
[TBL] [Abstract][Full Text] [Related]
26. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice.
Ohnishi K; Bonavida B
Leukemia; 1993 Nov; 7(11):1801-6. PubMed ID: 8231249
[TBL] [Abstract][Full Text] [Related]
27. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
[TBL] [Abstract][Full Text] [Related]
28. Cyclophosphamide treatment of an SJL murine B-cell lymphoma increases the proportion of suppressive CD8+ over tumor-stimulatory CD4+ T-lymphocytes.
Wrone-Smith T; Cankovic M; VanBuren E; Lerman S
Leuk Res; 1993 Nov; 17(11):967-75. PubMed ID: 8231237
[TBL] [Abstract][Full Text] [Related]
29. Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells.
DeKruyff RH; Brown PH; Thorbecke GJ; Ponzio NM
J Immunol; 1985 Nov; 135(5):3581-6. PubMed ID: 2413126
[TBL] [Abstract][Full Text] [Related]
30. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
Wilbur SM; Marelli O; Bonavida B
Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
[TBL] [Abstract][Full Text] [Related]
31. T-helper-cell-specific monoclonal antibody inhibits growth of B-cell lymphomas in syngeneic SJL/J mice.
Alisauskas RM; Ponzio NM
Cell Immunol; 1989 Apr; 119(2):286-303. PubMed ID: 2467748
[TBL] [Abstract][Full Text] [Related]
32. IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-gamma.
Horvath-Arcidiacono JA; Mostowski HS; Bloom ET
Int Immunol; 1996 May; 8(5):661-73. PubMed ID: 8671653
[TBL] [Abstract][Full Text] [Related]
33. Low frequency of NK-cell progenitors and development of suppressor cells in IL-2-dependent cultures of spleen cells from low NK-reactive SJL/J mice.
Migliorati G; Herberman RB; Riccardi C
Int J Cancer; 1986 Jul; 38(1):117-25. PubMed ID: 2424846
[TBL] [Abstract][Full Text] [Related]
34. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus.
Tsiagbe VK; Yoshimoto T; Asakawa J; Cho SY; Meruelo D; Thorbecke GJ
EMBO J; 1993 Jun; 12(6):2313-20. PubMed ID: 8389694
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
36. CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
Hömberg N; Adam C; Riedel T; Brenner C; Flatley A; Röcken M; Mocikat R
Int J Cancer; 2014 Dec; 135(12):2825-33. PubMed ID: 24771135
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the molecules on SJL/J lymphomas which stimulate syngeneic T cells.
Brown PH; Thorbecke GJ
J Immunol; 1985 Nov; 135(5):3572-80. PubMed ID: 3900211
[TBL] [Abstract][Full Text] [Related]
38. CD8+ T cells inhibit immunoglobulin E synthesis in low responder SJL/J mice.
Yang M; Cao Y; Mohapatra SS
Immunology; 1998 Feb; 93(2):230-7. PubMed ID: 9616373
[TBL] [Abstract][Full Text] [Related]
39. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
40. The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype.
Katz JD; Ohnishi K; Lebow LT; Bonavida B
J Exp Med; 1988 Nov; 168(5):1553-62. PubMed ID: 2460577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
